ライフサイエンスコーパス: who

1 The exclusion criteria were patients who (1) first presented with GMG, (2) were unable to ide

2 Candidates who accepted had a brief perioperative risk period withi

3 Patients who achieved cCR were managed nonoperatively.

4 reated with the same therapeutic regimen but who achieved different treatment outcomes.

5 y endpoint of the proportion of participants who achieved this concentration by week 96, assessed in

6 iority neglected zoonotic diseases for which WHO advocates control.

7 ference organizers, funders and institutions who are able to do so to consider how they can mitigate

8 s there is no cure, thousands of individuals who are alive at present will succumb to the disease.

9 Suitable candidates include patients who are at high immunologic risk because of sensitizatio

10 of CRC screening for patients with diabetes, who are at higher risk of early-onset CRC than the gener

11 patients with advanced chronic liver disease who are at increased risk for a first hepatic decompensa

12 suggest endoscopic screening of individuals who are at increased risk for Barrett's esophagus (BE) a

13 d egg OIT, but more frequent in participants who are BE-reactive.

14 Dosing symptom frequency in participants who are BE-tolerant was similar with BE and egg OIT, but

15 y be to target interventions toward children who are exposed to adversity, particularly during sensit

16 Patients who are HLA-A*01:01pos could benefit from such products,

17 Patients with opioid use disorder (OUD) who are hospitalized for serious infections requiring pr

18 er will be useful for biomedical researchers who are interested in finding salivary protein biomarker

19 19 is rare in previously healthy individuals who are less than 50 years of age, affecting probably no

20 560 Facebook users, we find that individuals who are more authentic in their self-expression also rep

21 The losses can be worse among those who are more vulnerable to exposure and this can be enha

22 these images is challenging for researchers who are not image analysis specialists.

23 from diagnosis of TB amongst those with HIV who are not yet in HIV care, and who would thus be ineli

24 rain injury and multiple sclerosis patients, who are often undergoing concurrent motor rehabilitation

25 nd, HIV-1 patients on antiretroviral therapy who are reported to exhibit chronically elevated levels

26 CE 6: Patients with suspected celiac disease who are seronegative but have villous atrophy and geneti

27 rvice providers, governments, and the people who are the intended beneficiaries of development progra

28 impact of living in quarters among families who are the most at risk, and factors including the open

29 essary treatment and monitoring for patients who are unlikely to develop cancer.

30 Women who attended religious services were less likely to deve

31 egative [TIMP-2]*[IGFBP7] at baseline, those who became positive (>0.3 units) after resuscitation had

32 ase 2019 (COVID-19) in infected individuals, who can either exhibit mild symptoms or progress toward

33 may not have access to medical professionals who can provide competent care.

34 ticity of dispersal morph ratio, individuals who can sense their sub-habitat and respond in this way

35 erventions to mitigate them even in patients who cannot be transplanted.

36 is way have an adaptive advantage over those who cannot.

37 As four NIH intramural women scientists who care deeply about scientific progress and the progre

38 he most vexing challenges faced by providers who care for patients after allogeneic hematopoietic cel

39 new definition in the fourth edition of the WHO classification of the digestive tract tumors of 2010

40 Of the 15,182 patients who completed a pancreatic surgery between 2016 and 2018

41 Plasma histidine (measured in subjects who completed all dosages for Studies 1 and 2) was eleva

42 Finally, for 5 patients who completed at least 3 PET/CT scans after administrati

43 The activity analysis included all patients who completed at least one full-scheduled post-treatment

44 emales) with a range of clinical disability, who completed the 6MWT wearing gait analysis system.

45 eived partial treatment, and 1 (0.2%) of 517 who completed treatment (1951, 290, and 31 cases/100 000

46 arrowly defined pain populations of patients who could tolerate the drug.

47 of metastatic disease (including 2 patients who declined additional treatment).

48 primiparous, 37% biparous, 30% multiparous) who delivered at Kaiser Permanente Northern California h

49 e data are available in patients with trauma who develop sepsis.

50 Women who developed GDM showed increased concentrations of MMP

51 74), with no difference in SVR between those who did and did not miss 7 consecutive doses (92% vs 93%

52 y to give a positive testimony than speakers who did not (P < .001).

53 r in patients with mild cognitive impairment who did not convert to Alzheimer's disease dementia.

54 cations was significantly higher in patients who did not cooperate during the procedure (p=0.04).

55 r patient, P < 0.001) compared with patients who did not develop new persistent use.

56 Compared with patients who did not experience dry eye, those who experienced si

57 on insulin secretion in people with obesity who did not improve insulin sensitivity despite marked (

58 e contacts, TB developed in 49 (9.8%) of 446 who did not initiate treatment, 8 (1.8%) of 443 who rece

59 Women who did not receive chemotherapy had a more than 97% rat

60 ere identified and matched 1:2 with patients who did not undergo bariatric surgery based on age, sex,

61 ed hydroxychloroquine with those in patients who did not, using a multivariable Cox model with invers

62 therapy compared with 3% (8 of 273) of those who did not.Conclusions: Household contacts who received

63 y metabolites that differed between patients who did vs did not develop ACLF and patients who did vs

64 who did vs did not develop ACLF and patients who did vs did not die during hospitalization and within

65 lungs obtained during autopsy from patients who died from acute respiratory distress syndrome (ARDS)

66 lungs obtained during autopsy from patients who died from Covid-19 and compared them with 7 lungs ob

67 e median baseline CD4 count for participants who died was 11 cells per muL.

68 However, individuals who died were more likely to have not mounted a cellular

69 nzymatic activities in the brains of persons who died with AD suggest that this reduction is the main

70 D-19, 45 (96%) of whom fully recovered and 2 who died.

71 Speakers who disclosed a COI were significantly more likely to gi

72 Infants who engaged in a larger number of CTs in daily life had

73 Among the 840 participants who enrolled (mean age, 59.3 years [SD, 8.6 years]; 60%

74 employees of a large hospital in Boston, MA, who enrolled in the study between September 2016 and Feb

75 udy in acute myeloid leukemia (AML) patients who entered complete remission.

76 ore, patients with early-stage breast cancer who experienced cardiovascular events after cancer diagn

77 were significantly higher in the population who experienced complications.

78 nflammatory marker) in MWA patients (n = 11) who experienced headaches and visual aura in the precedi

79 l oscillations between individuals with cLBP who experienced movement-evoked pain and pain-free contr

80 tients who did not experience dry eye, those who experienced significant dry eye (ie, daily/almost da

81 (8 mg/kg, 6x, monthly) from 12 cAMR patients who failed standard of care treatment with intravenous i

82 article emission of a coughing superemitter, who for unclear reasons emitted up to two orders of magn

83 All mothers who gave birth from 2008 to 2016 while living within 15

84 Users familiar with cryo-electron microscopy who get basic training in dual-beam microscopy can compl

85 reas where air quality does not meet current WHO guidelines, combined with the knowledge that polluta

86 Patients with Parkinson's disease who had 2 h or more of off time per day with predictable

87 Patients who had a first attempt of surgery within the previous 2

88 ctive study included the records of patients who had a minimum of two dental exams at least 12 months

89 the period 1 October 2008-30 September 2013 who had a urinalysis performed during the 30-day preoper

90 nt for at least 4 weeks before screening and who had an LDL cholesterol level of 130 mg per deciliter

91 setts General Hospital between 1990 and 2016 who had available CT angiography (CTA) or digital subtra

92 wo groups of inpatients with severe COVID-19 who had been discharged or died in Jin Yin-tan hospital

93 Among the 49 survivors treated with ECMO, 32 who had been treated at the largest centre reported sati

94 esity-related steatosis, only 70 individuals who had controlled attenuation parameters < 296 dB/m, BM

95 , we randomly assigned hospitalized patients who had Covid-19 without end-organ failure in a 1:1 rati

96 hted controls and sight-recovery individuals who had developed cataracts later in childhood: both gro

97 ry outcome was the proportion of adolescents who had died or had a viral load of at least 1000 copies

98 of activated T cells compared with patients who had fewer risk factors, but these cells showed impai

99 We compared 16 patients who had GHPs showing neoplastic transformation with 39 p

100 he mortality rate among the 835 participants who had initiated ART was 1.9 per 100 person-years (95%

101 organ response was 29% among the 24 patients who had measurable organ involvement.

102 Considering participants who had moderate and severe symptoms (23 to 100 points i

103 ironment in a prospective cohort of patients who had nephrectomy for localised RCC at MSK.

104 g neoplastic transformation with 39 patients who had non-neoplastic GHPs.

105 umab, pertuzumab, and trastuzumab emtansine, who had or did not have brain metastases, to receive eit

106 n aggressive thyroid cancers and in patients who had poorer outcomes following RAI treatment.

107 rade; 9 primary tumors, 34 recurrent tumors) who had preoperative (time before surgery: median, 23 d;

108 ficantly different from 0; p=0.655) in those who had received >=15 doses (n=20).

109 ly different from 0; p=0.351 in the patients who had received <15 doses (n=34), and -0.0135+/-0.1332

110 Patients 10 to 17 years of age who had received stable lipid-lowering treatment for at

111 ts of the Northern Finland Birth Cohort 1966 who had reported LBP over the previous 12 months and had

112 rts of pregnant women hospitalized with ARFI who had testing for influenza viruses by reverse-transcr

113 ohort, we assigned (in a 3:1 ratio) patients who had the option of using at least one fully active, a

114 onsecutive adult liver transplant recipients who had their surgery between July 2008 and December 201

115 PV was defined as the proportion of patients who had true-positive to all positive findings.

116 nsecutive patients with suspected stable CAD who had undergone coronary computed tomographic angiogra

117 e AF Genetics Consortium identified patients who had undergone de novo AF ablation.

118 cedures were reviewed by local endoscopists, who had undergone similar formal SB-VCE review training.

119 CVD) is the leading cause of death in women, who have a notable increase in the risk for this disease

120 rs in low-income and middle-income countries who have compromised development.

121 our defining sexually active women as those who have ever had sex.

122 nsitization to alloantigens, including those who have exhibited early onset or accelerated cardiac al

123 ull time, which is not feasible for students who have family, work, or housing commitments.

124 nefit extending to patients without diabetes who have heart failure with reduced ejection fraction.

125 esponses, in particular in older individuals who have increased CD39 expression.

126 uce cardiovascular risk in patients with CKD who have normophosphatemia.

127 uals of African or Middle Eastern ancestries who have on average a reduced number of circulating whit

128 India is concentrated among 3.1 million men who have sex with men (MSM) and 1.1 million people who i

129 s among high-risk populations, including men who have sex with men (MSM) and transgender women, in Ba

130 nded a change in blood donor deferral of men who have sex with men (MSM) from an indefinite to a 12-m

131 The World Health Organization's (WHO) hepatitis C virus (HCV) elimination target of an 80

132 We, the WHO HIVResNet working group, defined central areas of fu

133 accuracy of risk estimation for individuals who inherit a monogenic risk variant.

134 7 intact sequences were from three children who initiated ART after 2.3 months of age, one of whom h

135 idered a successful outcome: first, a person who initiates PrEP must not seroconvert; second, there s

136 and central Asia, particularly among people who inject drugs (PWID), it is crucial to effectively sc

137 ve sex with men (MSM) and 1.1 million people who inject drugs (PWID), with a mean incidence of 0.9-1.

138 iciency virus (HIV) infections among persons who inject drugs (PWID).

139 People who inject drugs identified as recently infected with HI

140 the prevalence of albuminuria amongst people who inject drugs in London and to test any potential ass

141 ith men were: 86%, 93%, 93%, 74%; for people who inject drugs: 94%, 88%, 85%, 70%; and for heterosexu

142 de with child's general dental practitioner, who is advised to treat the child as being at high carie

143 inued to be on the rise in recent years, but who is diagnosed changed during the study period.

144 ual" areas of congenitally blind individuals who lack visual imagery.

145 c pain; and (3) one-year survivors with pain who lived within 50 km from the study hospital.

146 She has an identical twin sister who maintained normal iris pigmentation during the entir

147 mentation among allergists and immunologists who manage infants for food allergy.

148 tests for the rapid detection of individuals who may carry the severe acute respiratory syndrome coro

149 Laryngeal cancer (LC) patients who meet the age and smoking criteria of the U.S. Preven

150 e only one-third of heterosexual individuals who met criteria for a past-year alcohol use disorder di

151 l (55%) and gay or lesbian (51%) individuals who met criteria for a past-year alcohol use disorder ha

152 at Indiana University between 1990 and 2016 who met inclusion criteria.

153 Response was assessed in all patients who met the eligibility criteria and who received at lea

154 sensus is lacking on the management in women who might subsequently become pregnant.

155 sulphate and 67% with antepartum haemorrhage who needed blood received it.

156 d the NIV trial (n = 18) compared with those who needed endotracheal intubation (n = 12) (median [int

157 ve prediction error), especially in subjects who obtained a better model fit.

158 435 people living with HIV aged 18-49 years who participated in pre-intervention and post-interventi

159 Out of 3520 subjects who participated in the study across the country, 269 (7

160 to the manufacturer from which the physician who performed the implantation received the largest paym

161 iatric patient with coronavirus disease 2019 who presented with seizure, right hemiparesis, and dysar

162 showed more in-group bias than Independents who professed the same political opinions.

163 tic tumor microenvironment and that patients who progress on gemcitabine-based regimens may benefit f

164 le (aged 18-29 years) in the United Kingdom, who provided questionnaire data and Magnetic Resonance I

165 2 with rebound viremia after stopping ART), who provided serial blood samples before death and their

166 e been shown to have self-image costs: Those who receive incentives view their actions less positivel

167 sk of AEs was noted among patients aged >=50 who received 3HP-SAT (aRR 0.37 [0.16-0.85] p=0.02).

168 All hospitalized patients who received a blood culture during hospitalization.

169 tool for graft failure in patients (n = 181) who received a kidney transplant in Olmsted County, MN (

170 5) with treatment-resistant depression (TRD) who received a single ketamine infusion (0.5 mg/kg) over

171 a: 313 (78%) without adjuvant therapy and 90 who received adjuvant chemotherapy with or without radia

172 The safety population included patients who received any dose of study treatment.

173 RR, 1.19; 95% CI, 1.06 to 1.34) and in those who received aprepitant or fosaprepitant.

174 atients who met the eligibility criteria and who received at least 8 weeks of therapy.

175 ion by week 96, assessed in all participants who received at least one dose of any study drug, regard

176 Safety was assessed in all participants who received at least one dose of study drug in terms of

177 Safety was assessed in all patients who received at least one dose of study drug.

178 and no prior diagnosis of bipolar disorder, who received at least one of the nine antidepressant med

179 n patients with relapsed or refractory DLBCL who received at least two lines of previous chemoimmunot

180 In contrast, HCV+ recipients who received ATG were at lower risk of acute rejection c

181 The trial enrolled 31 patients who received bendamustine on days 1 and 2 (100 mg/m(2) i

182 s recorded on POD1 for 1285 (27.3%) patients who received drains.

183 In patients with COVID-19 who received ECMO, both estimated mortality 90 days afte

184 We compared outcomes in patients who received hydroxychloroquine with those in patients w

185 uding bone loss) may be observed in patients who received IACS injections.

186 er risk of acute rejection compared to those who received IL2RA (1-y crude incidence = 11.6% versus 1

187 ccurred in none of the 76 household contacts who received INH preventive therapy compared with 3% (8

188 who did not.Conclusions: Household contacts who received INH preventive therapy had a lower incidenc

189 analyzed two independent cohorts of patients who received left prefrontal transcranial magnetic stimu

190 with postthrombotic femoral veins and those who received multiple stents were characterized by the h

191 did not initiate treatment, 8 (1.8%) of 443 who received partial treatment, and 1 (0.2%) of 517 who

192 (4%) who received SNF472 and 5 patients (6%) who received placebo.

193 Patients who received pretransplant dialysis treatment in a state

194 Additionally, 1 of 12 patients who received radioiodine for differentiated thyroid carc

195 Death occurred in 7 patients (4%) who received SNF472 and 5 patients (6%) who received pla

196 stry for 35 849 T2DM kidney disease patients who received transplant between 2000 and 2016 and surviv

197 The switch to WHO-recommended dolutegravir (DTG)-based regimens could

198 Implementation of WHO-recommended NCD policies is increasing over time.

199 WHO recommends the use of psychological interventions as

200 lations were classified according to income, WHO region, gender, age, occupation and publication date

201 Smoking expectant fathers who registered with their pregnant partners were invited

202 70-90% of surgeons who regularly perform LS report musculoskeletal symptoms

203 n did high-risk, age-matched HTLV-1 carriers who remained ATL-free after a median of 10 years of foll

204 At birth, infants who remained healthy had significantly higher RSV-A and

205 on had 3-times higher risk compared to those who remained negative (21.8% vs 8.5%, p=0.01; OR 3.0, 95

206 Those who report SDs prior to a traumatic event are at greater

207 ary data analysis for 1,022 women aged 15-24 who reported ever having sex: 326 adolescents (15-19 yea

208 over SAR in patients with renal dysfunction who require CABG.

209 idered a life-changing solution for patients who require regular needle injections.

210 le only when they were derived from patients who responded to lithium; they featured sustained activi

211 Essentially all allergists/immunologists who responded to the survey reported full or partial Gui

212 Despite the WHO's call for universal drug susceptibility testing for

213 sensitivity of >90%, in accordance with the WHO's target-product profile for a triage test.

214 ositis (Radiation Therapy Oncology Group and WHO scales) and 36-mo survival.

215 20%) screened positive for any MHD: of those who screened positive for PTSD (7.9%, N = 42), all had c

216 >=40 years, taking >=1 glaucoma medication, who self-reported poor adherence) completed a baseline s

217 successfully identifying groups of patients who share features in common, more than current DSM diag

218 hat anti-VEGF treated patients with wet AMD, who showed no exudative signs on the day of blood drawin

219 logic findings with experienced pathologists who specialize in gastroenterology.

220 ly lower 2 hours after NIV start in patients who successfully completed the NIV trial (n = 18) compar

221 Many people who survive PML are left with neurological sequelae and

222 1654 participants in the intervention group who swallowed the Cytosponge device successfully, 221 (1

223 o tested positive for COVID-19 with patients who tested negative for COVID-19 regarding the presence

224 er exact tests were used to compare patients who tested positive for COVID-19 with patients who teste

225 The prognosis for patients who undergo concurrent resection of CLM/EHD is unclear a

226 ory of brain radiation therapy or craniotomy who underwent 1.5-T and 3-T same-plane T1-weighted MRI (

227 udy of 20 consecutive patients with COVID-19 who underwent 21 interventional radiology procedures bet

228 A total of 151 patients who underwent a major hepatic resection were randomized

229 ethods In this retrospective study, patients who underwent ablation therapy for presumed HCC followed

230 ely into a multicenter registry for patients who underwent attempted TPVR with a Sapien XT or S3 valv

231 Patients who underwent bariatric surgery were identified and matc

232 e SSI was detected in 11 (1.4%) of the women who underwent caesarean operations.

233 Medicare beneficiaries who underwent elective colectomy, coronary artery bypass

234 and 2016, patients from 20 European Centers who underwent esophageal cancer surgery, and were diseas

235 Women who underwent FGM/C were around twice as likely as non-F

236 djusted hazard ratio was highest in patients who underwent isolated mitral (2.18; 95% CI, 1.71-2.77)

237 ty was evaluated on a sample of 120 patients who underwent laparoscopic Roux-en-Y gastric bypass proc

238 h preserved ejection fraction (HFpEF) 51.9%] who underwent noncardiac surgery, 41.1% had cardiopulmon

239 luded were 300 adult patients with cirrhosis who underwent outpatient physical frailty testing using

240 For patients who underwent outpatient procedures, new persistent opio

241 eline eGFR with AKI incidence among patients who underwent PCI at Duke University Medical Center betw

242 lesions, and from 44% to 75% among patients who underwent percutaneous coronary intervention.

243 Patients who underwent phacoemulsification cataract surgery from

244 Among 22,377 patients who underwent primary antireflux surgery in the Hospital

245 r retrospective review, consecutive patients who underwent primary vitrectomy for TRD from proliferat

246 GIS endoscopy performed due to deep anemia, who underwent simultaneous cesarean section and subtotal

247 Among the 404 men who underwent subsequent radical prostatectomy, combined

248 and adjacent nontumor tissues) from patients who underwent surgery and gemcitabine chemotherapy and a

249 nts (mean age, 48 [SD, 11] years; 66% women) who underwent surgery with in-network primary surgeons a

250 erials and Methods Patients with VHL disease who underwent surgical resection of tumors between Novem

251 a multicenter study including 4949 patients who underwent TAVR (mean age, 81+/-8 years, mean Society

252 In the subset of patients who underwent tricuspid valve surgery (n = 344), a post-

253 A retrospective chart review of patients who underwent vitrectomy using PFCL tamponade for RD rep

254 ization was achieved in 95% (21/22) of women who used the Callascope for self-imaging.

255 es were reviewed by an abdominal radiologist who was blinded to the pathological results.

256 We collected data of patients who were admitted to hospital with a clinical diagnosis

257 A total of 139,367 individuals who were admitted to one of the 335 participating ICUs b

258 ed our results with 23,557 subjects with CF, who were also matched with controls; as the relative odd

259 sually 2 per case, with unrelated conditions who were at the same hospital at the same time were matc

260 Patients (aged >=16 years) who were being treated non-operatively for a primary Ach

261 ssessments; and included >= 450 participants who were current residents of an SSA country, at least 5

262 end the proportion of people living with HIV who were diagnosed was significantly higher in intervent

263 dren were estimated to suffer FA among those who were eligible but refused DBPCFC.

264 We recruited consecutive surviving patients who were English speaking, consented to follow-up, and w

265 hage from proliferative diabetic retinopathy who were enrolled from November 2016 to December 2017.

266 in people with human immunodeficiency virus who were exposed to darunavir (DRV) but not to atazanavi

267 th Professionals Follow-up Study (1986-2016) who were free of CVD and cancer at baseline.

268 fessionals Follow-up Study (HPFS; 1986-2016) who were free of T2D, cardiovascular disease, and cancer

269 ncluded mechanically ventilated ICU patients who were given moderate-to-high doses of opioids and exp

270 study also found that, although individuals who were higher on general neuroticism lived shorter liv

271 and immune factors in pregnant African women who were HIV-uninfected (n = 314) versus HIV-infected (n

272 Participants (aged 18-65 years), who were HIV-uninfected and at low-risk for HIV, were ra

273 ts discharged from the ED and 608% for those who were hospitalized.

274 ere were 246 children living with HIV (HIV+) who were initiated on ART before 3 years of age in a pri

275 a secondary analysis of patients with ARDS, who were invasively ventilated on controlled modes and e

276 ents with early-stage PD (duration <3 years) who were not taking dopaminergic medications at enrollme

277 081 adult kidney transplantation candidates who were offered a DCD50 kidney that was eventually acce

278 ewed for individuals harboring P/LP variants who were predicted to develop disease (G+).

279 Of 152 patients who were randomized (mean [SD] age, 46 [13] years; 109 [

280 Among 330 patients who were randomized (mean age, 68 years; 181 [55%] women

281 mong 45 healthy adults (18-55 years of age), who were randomized to receive 2 doses-separated by 21 d

282 Of 40 participants who were randomized, 17 dipyridamole and 18 placebo reci

283 nd ventilated for an additional 48 hours and who were receiving enteral nutrition or expected to star

284 e and administered to the study participants who were recruited with a multi-stage sampling technique

285 individuals without known intestinal disease who were referred for colorectal cancer screening.

286 up even though both groups included patients who were removed from the study and treated with topical

287 2 study in patients with polycythaemia vera who were resistant to or intolerant of hydroxyurea.

288 Oncology Group performance status of 0 or 1, who were scheduled to have a type 2 or 3 radical hystere

289 nics, we identified 13 657 eligible patients who were sent an introductory letter with 14 days to opt

290 table in SARS-CoV-2 convalescent individuals who were seronegative for anti-SARS-CoV-2 antibodies tar

291 kade between June 2011 and December 2017 and who were split into training (n = 97) and test (n = 49)

292 ding in Bogo or Balamban, Cebu, Philippines, who were to be aged 9-14 years at the time of a mass den

293 All severely injured patients who were transferred to the hybrid suite for emergent in

294 histologically confirmed stage IIIB-IV NSCLC who were treated with immune checkpoint blockade between

295 Patients who were untreated showed no change in any FDG PET or ca

296 ules, are publicly available for researchers who wish to annotate their own sequences.

297 onal Health and Nutrition Examination Survey who wore an accelerometer for up to 7 days ( from 2003-2

298 new generation of scientists and clinicians who work in multidisciplinary teams to solve the pressin

299 nistry of Foreign Affairs, UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Developmen

300 se with HIV who are not yet in HIV care, and who would thus be ineligible for a LAM test under curren